News & Insights

Portfolio News 11 Feb 2026

Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis

View Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis

Claret Insight 28 Jan 2026

The GLP-1 Pill Race: Pharma’s New Frontier

View The GLP-1 Pill Race: Pharma’s New Frontier

Portfolio News 14 Jan 2026

Liechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.

View Liechtenstein’s spectrum award to Open Cosmos propels Europe in the space tele-communications infrastructure race.

Investment Announcement 14 Jan 2026

Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A

View Claret Capital Partners Completes €35M Investment in Holidu to Fuel Growth and M&A

Investment Announcement 8 Jan 2026

Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company

View Claret Capital Partners Invests in SIS Medical, Marking 200th Portfolio Company

Claret News 9 Nov 2025

Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!

View Claret Capital Partners Named Venture Debt Provider of the Year for Second Year Running!

Investment Announcement 2 Oct 2025

Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth

View Deciphex Secures €15M Venture Debt Funding from Claret Capital Partners to Accelerate Growth

Investment Announcement 1 Oct 2025

Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma

View Claret Capital Partners Announces €10M Growth Funding in Yseop to Scale Generative AI Platform for Life Sciences and Pharma